Proliferative T cell responses have been reported in the human against both insulin and proinsulin, especially in recent-onset T1D patients and prediabetic individuals [29–31, 35] although also in nondiabetic subjects in some reports [36, 40]. Here, INS is linked to type 1 diabetes mellitus.